Australia markets close in 3 hours 19 minutes

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1719-0.0184 (-9.67%)
At close: 04:00PM EDT
0.1730 +0.00 (+0.64%)
After hours: 07:16PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,277
21,453
23,191
16,267
7,178
Selling general and administrative
10,470
10,806
8,758
6,930
6,556
Total operating expenses
28,747
32,259
31,949
23,197
13,734
Operating income or loss
-28,747
-32,259
-31,949
-23,197
-13,734
Interest expense
-
-
-
-
62
Total other income/expenses net
936
1,239
7,297
-7,731
1,955
Income before tax
-27,680
-30,910
-24,639
-30,774
-11,841
Income tax expense
-
-
-
-
0
Income from continuing operations
-27,680
-30,910
-24,639
-30,774
-11,841
Net income
-27,680
-30,910
-24,639
-30,774
-13,335
Net income available to common shareholders
-27,680
-30,910
-24,639
-30,774
-13,335
Basic EPS
-
-
-0.39
-0.90
-0.64
Diluted EPS
-
-
-0.39
-0.90
-0.64
Basic average shares
-
-
62,620
34,142
20,975
Diluted average shares
-
-
62,620
34,142
20,975
EBITDA
-
-30,296
-29,995
-21,239
-11,771